{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T05:08:26Z","timestamp":1786597706880,"version":"build-2736575974"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Neurol Neurosci Rep"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s11910-025-01432-8","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:02:32Z","timestamp":1751360552000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Uncommon Non-MS Demyelinating Disorders of the Central Nervous System"],"prefix":"10.1007","volume":"25","author":[{"given":"Angshuman","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasis","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambar","family":"Chakravarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"key":"1432_CR1","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1111\/j.1749-6632.1965.tb20235.x","volume":"122","author":"GA Schumacher","year":"1965","unstructured":"Schumacher GA, Beebe GW, Kibler RF. Problems of experimental trials of therapy in multiple sclerosis: report by the panel on the evaluation of experimental trials of therapy in multiple sclerosis. Ann N Y Acad Sci. 1965;122:552\u201368.","journal-title":"Ann N Y Acad Sci"},{"issue":"3","key":"1432_CR2","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1002\/ana.410130302","volume":"13","author":"CM Poser","year":"1983","unstructured":"Poser CM, Paty DW, Schoenberg L, McDonald WI, et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol. 1983;13(3):227\u201331.","journal-title":"Ann Neurol"},{"issue":"2","key":"1432_CR3","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/S1474-4422(17)30470-2","volume":"17","author":"AJ Thompson","year":"2018","unstructured":"Thompson AJ, Banwell BL, Barkhof F, et al. Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol. 2018;17(2):162\u201373.","journal-title":"Lancet Neurol"},{"key":"1432_CR4","doi-asserted-by":"publisher","DOI":"10.55788\/74e71270","author":"X Montalban","year":"2024","unstructured":"Montalban X. McDonald criteria allow earlier and more precise MS diagnosis. ECTRIMS. 2024. https:\/\/doi.org\/10.55788\/74e71270.","journal-title":"ECTRIMS"},{"key":"1432_CR5","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1056\/NEJMra1904655","volume":"387","author":"DM Wingerchuk","year":"2022","unstructured":"Wingerchuk DM, Lucchinetti CF. Neuromyelitis Optica spectrum disorder. N Engl J Med. 2022;387:631\u20139.","journal-title":"N Engl J Med"},{"key":"1432_CR6","doi-asserted-by":"publisher","first-page":"885218","DOI":"10.3389\/fneur.2022.885218","volume":"13","author":"E Sechi","year":"2022","unstructured":"Sechi E, Cacciaguerra L, Chen JJ, et al. Myelin oligodendrocyte glycoprotein antibody associated disease (MOGAD): a review of clinical and MRI features, diagnosis and management. Front Neurol. 2022;13:885218.","journal-title":"Front Neurol"},{"key":"1432_CR7","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.msard.2018.07.025","volume":"25","author":"R Narayana","year":"2018","unstructured":"Narayana R, Simpson A, Fritschea K, et al. MOG antibody disease: A review of MOG antibody seropositive neuromyelitis Optica spectrum disorder. Multiple Scler Relat Disorders. 2018;25:66\u201372.","journal-title":"Multiple Scler Relat Disorders"},{"issue":"4","key":"1432_CR8","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1177\/1352458515593406","volume":"22","author":"S Ramanathan","year":"2016","unstructured":"Ramanathan S, Prelog K, Barnes EH, et al. Radiological differentiation of optic neuritis with Myelin oligodendrocyte glycoprotein antibodies, Aquaporin\u2013\u20094 antibodies and multiple sclerosis. Multiple Scler. 2016;22(4):470\u201382.","journal-title":"Multiple Scler"},{"issue":"3","key":"1432_CR9","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1001\/jamaneurol.2018.4053","volume":"76","author":"D Dubey","year":"2019","unstructured":"Dubey D, Pittock SJ, Krecke KN. Clinical, radiologic, and prognostic features of myelitis associated with Myelin oligodendrocyte glycoprotein autoantibody. JAMA Neurol. 2019;76(3):301\u20139.","journal-title":"JAMA Neurol"},{"issue":"17","key":"1432_CR10","doi-asserted-by":"publisher","first-page":"e1642","DOI":"10.1212\/WNL.0000000000006392","volume":"91","author":"E Shosha","year":"2018","unstructured":"Shosha E, Dubey D, Palace J, et al. Area Postrema syndrome: frequency, criteria, and severity in AQP4-IgG- positive NMOSD. Neurology. 2018;91(17):e1642\u201351.","journal-title":"Neurology"},{"key":"1432_CR11","doi-asserted-by":"publisher","first-page":"100114","DOI":"10.1016\/j.nerep.2022.100114","volume":"2","author":"J Moura","year":"2022","unstructured":"Moura J, Pinto E, Coutinho E, et al. Recurrent diencephalic involvement as the sole manifestation of anti-aquaporin 4 antibody positive disorder in an adult patient. Neuroimmunol Rep. 2022;2:100114.","journal-title":"Neuroimmunol Rep"},{"key":"1432_CR12","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s12883-022-02985-8","volume":"22","author":"B Yang","year":"2022","unstructured":"Yang B, Guo L, Yang X, Yu N. The pathogenesis and treatment of posterior reversible encephalopathy syndrome after neuromyelitis Optica spectrum disorder: a case report and literature review. BMC Neurol. 2022;22:493.","journal-title":"BMC Neurol"},{"issue":"2","key":"1432_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1002\/ana.26549","volume":"93","author":"C Valencia-Sanchez","year":"2023","unstructured":"Valencia-Sanchez C, Guo Y, Krecke KN, et al. Cerebral cortical encephalitis in Myelin oligodendrocyte glycoprotein antibody associated disease. Ann Neurol. 2023;93(2):297\u2013302.","journal-title":"Ann Neurol"},{"issue":"10","key":"1432_CR14","doi-asserted-by":"publisher","first-page":"2481","DOI":"10.1007\/s00415-019-09440-8","volume":"266","author":"A Budhram","year":"2019","unstructured":"Budhram A, Miriam A, Le C, et al. Unilateral cortical FLAIR-hyperintense lesions in Anti-MOG associated encephalitis with seizures (FLAMES): characterisation of a distinct clinico-radiographic syndrome. J Neurol. 2019;266(10):2481\u20137.","journal-title":"J Neurol"},{"issue":"2","key":"1432_CR15","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1212\/WNL.0000000000001729","volume":"85","author":"DM .Wingerchuk","year":"2015","unstructured":"Wingerchuk DM, Banwell B, Bennett JL. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders. Neurology. 2015;85(2):177\u201389.","journal-title":"Neurology"},{"issue":"3","key":"1432_CR16","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1016\/S1474-4422(22)00431-8","volume":"22","author":"B Banwell","year":"2023","unstructured":"Banwell B, Bennett JL, Marignier R, et al. Diagnosis of Myelin oligodendrocyte glycoprotein antibody associated disease: international MOGAD panel proposed criteria. Lancet Neurol. 2023;22(3):268\u201382.","journal-title":"Lancet Neurol"},{"issue":"3","key":"1432_CR17","first-page":"815","volume":"25","author":"EP Flanagan","year":"2019","unstructured":"Flanagan EP. Neuromyelitis Optica spectrum disorder and other non-multiple sclerosis central nervous system inflammatory diseases. Continuum (Minneap Min). 2019;25(3):815\u201344.","journal-title":"Continuum (Minneap Min)"},{"key":"1432_CR18","first-page":"787630","volume":"2012","author":"M Bonnan","year":"2012","unstructured":"Bonnan M, Cabre P. Plasma exchange in severe attacks of neuromyelitis Optica. Mult Scler Int. 2012;2012:787630.","journal-title":"Mult Scler Int"},{"issue":"4","key":"1432_CR19","doi-asserted-by":"publisher","first-page":"e200124","DOI":"10.1212\/NXI.0000000000200124","volume":"10","author":"F Paul","year":"2023","unstructured":"Paul F, Marignier R, Palace J, et al. International Delphi consensus on the management of AQP4-IgG\u2009+\u2009NMOSD: recommendations for eculizumab, inebilizumab, and satralizumab. Neurol Neuroimmunol Neuroiflamm. 2023;10(4):e200124.","journal-title":"Neurol Neuroimmunol Neuroiflamm"},{"key":"1432_CR20","doi-asserted-by":"publisher","first-page":"100165","DOI":"10.1016\/j.jcvp.2023.100165","volume":"3","author":"MSM Krishna Mohan","year":"2023","unstructured":"Krishna Mohan MSM, Vijayaraghavan A, Sundaram S, et al. Post infectious neurological complications of COVID19 - a tertiary care center experience. J Clin Virol Plus. 2023;3:100165.","journal-title":"J Clin Virol Plus"},{"issue":"308","key":"1432_CR21","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.jneuroim.2017.01.001","volume":"15","author":"S Perlman","year":"2017","unstructured":"Perlman S, Zhao J. Roles of regulatory T-cells and IL-10 in virus induced demyelination. J Neuroimmunol. 2017;15(308):6\u201311.","journal-title":"J Neuroimmunol"},{"issue":"4","key":"1432_CR22","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1007\/s13244-018-0608-3","volume":"9","author":"24M Moghaddam","year":"2018","unstructured":"Moghaddam 24\u00a0M, Bhatt S. Location, length, and enhancement: systematic approach to differentiating intramedullary spinal cord lesions. Insights Imaging. 2018;9(4):511\u201326.","journal-title":"Insights Imaging"},{"key":"1432_CR23","doi-asserted-by":"crossref","unstructured":"Trebst C, Raab P, Voss EV, Rommer P, Abu-Mugheisib M, Zettl UK, Stangel M. Longitudinal extensive transverse myelitis\u2013it\u2019s not all neuromyelitis Optica. Nat Rev Neurol. 2011;1(7):688\u201398.","DOI":"10.1038\/nrneurol.2011.176"},{"key":"1432_CR24","doi-asserted-by":"crossref","unstructured":"Dale RC, Tantsis E. MRI features of acute disseminated encephalomyelitis. In: Chabas D, Waunbant EL, editors. Demyelinating disorders of the central nervous system in childhood. Cambridge University Press; 2011. pp. 202\u201311.","DOI":"10.1017\/CBO9780511974373.019"},{"issue":"12","key":"1432_CR25","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1016\/j.jocn.2008.05.002","volume":"15","author":"W Huynh","year":"2008","unstructured":"Huynh W, Cordato DJ, Kehdi E, et al. Post vaccination encephalomyelitis: literature review and illustrative case. J Clin Neurosci. 2008;15(12):1315\u201322.","journal-title":"J Clin Neurosci"},{"key":"1432_CR26","doi-asserted-by":"crossref","unstructured":"Wang SY, Sun JF, Lou P, et al. Immunogenicity and safety of human diploid cell vaccine vs. purified Vero cell vaccine vs purified chick embryo cell vaccine, used in post exposure prophylaxis: a systematic review and meta-analysis. Hum Vaccin Immunother. 2022;18(1):2027714.","DOI":"10.1080\/21645515.2022.2027714"},{"key":"1432_CR27","unstructured":"Chakravarty A. Neurologic illness following post exposure prophylaxiswith purified chick embryo cell antirabies vaccine. J Assoc Physicians India. 2001;49:927\u20138."},{"key":"1432_CR28","doi-asserted-by":"crossref","unstructured":"Lido JW, Conti-Kelly AM, Greco P et al. Anti phospholipid antibodies in patients with multiple sclerosis and MS-like illnesses: MS or APS? Lupus. 1999;8(2):109\u2013\u200915.","DOI":"10.1191\/096120399678847461"},{"key":"1432_CR29","doi-asserted-by":"crossref","unstructured":"Kalra S, Silman A, Akman-Demir G, et al. Diagnosis and management of Neuro-Behcet\u2019s disease: international consensus recommendations. J Neurol. 2013;261(9):1662\u201376.","DOI":"10.1007\/s00415-013-7209-3"},{"issue":"8697","key":"1432_CR30","first-page":"1078","volume":"335","author":"32.Criteria for diagnosis of Beh\u00e7et\u2019s disease","year":"1990","unstructured":"Criteria for diagnosis of Beh\u00e7et\u2019s disease. International study group for behcets disease. Lancet. 1990;335(8697):1078\u201380.","journal-title":"Lancet"},{"key":"1432_CR31","doi-asserted-by":"publisher","unstructured":"Kiafar M, Tahereh Frazier S, Kasaeian A, et al. Diagnosis of beh\u00e7et\u2019s disease: clinical characteristics, diagnostic criteria, and differential diagnosis. BMC Rheumatol. 2021;5(2). https:\/\/doi.org\/10.1186\/s41927-020-00172-1.","DOI":"10.1186\/s41927-020-00172-1"},{"key":"1432_CR32","doi-asserted-by":"crossref","unstructured":"Dudsek A, Rimmele F, Tesar S, et al. CLIPPERS: chronic lymphocytic inflammation with Pontine perivascular enhancement responsive to steroids. Review of an increasingly recognised entity within the spectrum of inflammatory central nervous system disorders. Clin Exp Immunol. 2014;175(3):385\u201396.","DOI":"10.1111\/cei.12204"},{"key":"1432_CR33","doi-asserted-by":"crossref","unstructured":"Tobin WO, Guo Y, Krecke KN, et al. Diagnostic criteria for chronic lymphocytic inflammation with Pontine perivascular enhancement responsive to steroids (CLIPPERS). Brain. 2017;140(9):2415\u201325.","DOI":"10.1093\/brain\/awx200"},{"key":"1432_CR34","doi-asserted-by":"crossref","unstructured":"Dierickx J, Vanhoenacker F, Merckaert V. Snowballs and icicles in susac\u2019s syndrome. J Belg Soc Radiol. 2021;105(1):24.","DOI":"10.5334\/jbsr.2441"},{"key":"1432_CR35","doi-asserted-by":"crossref","unstructured":"Krainer J, Siebenhandl S, Weinhausel A. Systemic autoinlammatory diseases. J Autoimmun. 2020;109:109421.","DOI":"10.1016\/j.jaut.2020.102421"},{"key":"1432_CR36","doi-asserted-by":"crossref","unstructured":"Diprose WK, Jordan A, Anderson NE. Autoinflammatory syndromes in neurology: when our first line of defence misbehaves. Pract Neurol. 2022;22:145\u201353.","DOI":"10.1136\/practneurol-2021-003031"},{"issue":"6","key":"1432_CR37","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1136\/practneurol-2018-001998","volume":"18","author":"39R Russell","year":"2018","unstructured":"Russell 39R, Dryden AL, Pinto MS, Lovett AA. Lyme disease: diagnosis and management. Pract Neurol. 2018;18(6):455\u201364.","journal-title":"Pract Neurol"},{"key":"1432_CR38","doi-asserted-by":"crossref","unstructured":"Mahajan VK. Lyme disease: an overview. Indian Dermatol Online J. 2023;14(5):594\u2013604.","DOI":"10.4103\/idoj.idoj_418_22"},{"key":"1432_CR39","doi-asserted-by":"crossref","unstructured":"Joly M, Conte C, Cazanave C, et al. Progressive multifocal leukoencephalopathy: epidemiology and spectrum of predisposing conditions. Brain. 2023;146(1):349\u201358.","DOI":"10.1093\/brain\/awac237"},{"key":"1432_CR40","first-page":"700","volume":"101","author":"42F Schweitzer","year":"2023","unstructured":"Schweitzer 42F, Sarah Laurent PD, PhD MD, Irene Cortese MD, Gereon R, Fink MD, Steffi Silling PD, Skripuletz T, Imke Metz MD, Mike MD. Wattjes, MD, phd, and Clemens warnke, MD. Progressive multifocal leukoencephalopathy pathogenesis, kempdiagnostic tools, and potential biomarkers of response to. Therapy Neurology\u00ae. 2023;101:700\u201313.","journal-title":"Therapy Neurology\u00ae"},{"key":"1432_CR41","doi-asserted-by":"crossref","unstructured":"Berger JR, Aksamit AJ, Clifford DB, et al. PML diagnostic criteria: consensus statement from the AAN neuroinfectious disease section. Neurology. 2013;80(15):1430\u201380.","DOI":"10.1212\/WNL.0b013e31828c2fa1"},{"key":"1432_CR42","doi-asserted-by":"crossref","unstructured":"Loes DJ, Fatemi A, Melhem ER. Analysis of MRI patterns aids prediction of progression in X-linked adrenoleukodystrophy. Neurology. 2003;61:369\u201374.","DOI":"10.1212\/01.WNL.0000079050.91337.83"},{"key":"1432_CR43","doi-asserted-by":"crossref","unstructured":"Gujral J, Sethuram S. An update on the diagnosis and treatment of adrenoleukodystrophy. Curr Opin Endocrinol Diabetes Obes. 2023;30(1):44\u201351.","DOI":"10.1097\/MED.0000000000000782"},{"key":"1432_CR44","doi-asserted-by":"crossref","unstructured":"Volmrich AM, Cuenant LM, Forghani I, et al. ABCD1 gene mutations: mechanisms and management of adrenomyeloneuropathy. Apple Clin Genet. 2022;15:111\u201323.","DOI":"10.2147\/TACG.S359479"},{"key":"1432_CR45","doi-asserted-by":"crossref","unstructured":"Hsu CL, Iwanowski P, Hsu CH, et al. Genetic diseases mimicking multiple sclerosis. Postgrad Med. 2021;133(7):728\u201349.","DOI":"10.1080\/00325481.2021.1945898"},{"key":"1432_CR46","doi-asserted-by":"crossref","unstructured":"Muthusami K, Sivadasan A, Dixon L, et al. Adult onset leukodystrophies: a practical guide, recent treatment updates, and future directions. Front Neurol. 2023 July 26;14:1219324.","DOI":"10.3389\/fneur.2023.1219324"},{"key":"1432_CR47","doi-asserted-by":"crossref","unstructured":"Wang X, Jiang Y, Wu P, et al. Less common phenotypes of Myelin oligodendrocyte glycoprotein antibody related diseases in children deserve more attention. Ped Res. 2024;96:731\u20139.","DOI":"10.1038\/s41390-024-03058-x"},{"key":"1432_CR48","doi-asserted-by":"crossref","unstructured":"Chaer LER, de Mendonca JM, de Negro MC, et al. Differential diagnosis between multiple sclerosis and leukodystrophies - A scoping review. J Neurol Sci. 2024;459:122969.","DOI":"10.1016\/j.jns.2024.122969"},{"key":"1432_CR49","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1038\/nrendo.2016.90","volume":"12","author":"S 51 Kemp","year":"2016","unstructured":"Kemp S, Huffnagel C, Linthorst GE, et al. Adrenoleukodystrophy - Neuroendocrine pathogenesis and redefinition of natural history. Nat Rev Endocrinol. 2016;12:606\u201315.","journal-title":"Nat Rev Endocrinol"},{"key":"1432_CR50","first-page":"62","volume":"14","author":"S Rodriguez-Leyva","year":"2019","unstructured":"Palau-Hernandez, Rodriguez-Leyva S, Shiguetomi-Medina I. Late onset adrenoleukodystrophy: A review related clinical case report. Neurol Sci. 2019;14:62\u20137.","journal-title":"Neurol Sci"},{"key":"1432_CR51","doi-asserted-by":"crossref","unstructured":"Tikka S, Baumann M, Siitonen M, Pasanen P, et al. CADASIL CARASIL Brain Pathol. 2014;24(5):525\u201344.","DOI":"10.1111\/bpa.12181"},{"key":"1432_CR52","doi-asserted-by":"crossref","unstructured":"Tan RY, Markus HS. Monogenic causes of stroke: Nowand the future. J Neurol. 2015;262(12):2601\u201316.","DOI":"10.1007\/s00415-015-7794-4"},{"issue":"1\u20132","key":"1432_CR53","first-page":"25","volume":"322","author":"55FA Di Donato","year":"2012","unstructured":"Di Donato 55FA, Bianchi I, Di Palma S, Taglia C, Dotti I. Hereditary cerebral small vessel diseases: a review. J Neurol Sci. 2012;322(1\u20132):25\u201330.","journal-title":"J Neurol Sci"},{"key":"1432_CR54","doi-asserted-by":"publisher","unstructured":"LeeJS, Kang C, Park SQ, Choi H, Sim A. KB. Clinical significance of cerebral microbleeds locations in CADASIL with R544C NOTCH3 mutation. PLoS ONE 10(2): e0118163. https:\/\/doi.org\/10.1371\/journal.pone.011816","DOI":"10.1371\/journal.pone.011816"},{"issue":"6","key":"1432_CR55","first-page":"1066","volume":"57","author":"R van den Boom","year":"2001","unstructured":"van den Boom R. Oberstein SAL. Et Al Cereb Microbleeds CADASIL Neurol. 2001;57(6):1066\u201370.","journal-title":"Et Al Cereb Microbleeds CADASIL Neurol"}],"container-title":["Current Neurology and Neuroscience Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01432-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11910-025-01432-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11910-025-01432-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T09:02:47Z","timestamp":1751360567000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11910-025-01432-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["1432"],"URL":"https:\/\/doi.org\/10.1007\/s11910-025-01432-8","relation":{},"ISSN":["1528-4042","1534-6293"],"issn-type":[{"value":"1528-4042","type":"print"},{"value":"1534-6293","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"20 June 2025","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"45"}}